Aimix amlodipine besilate/irbesartan regulatory update

Dainippon said Japan's Ministry of Health, Labor and Welfare (MHLW) approved Aimix amlodipine besilate/irbesartan to treat hypertension. Dainippon and Shionogi & Co. Ltd. (Tokyo:4507; Osaka:4507, Osaka, Japan) will co-market the product in Japan under a June deal (see BioCentury, June 11). The product is an oral combination of amlodipine besilate, a calcium channel blocker, and irbesartan, an angiotensin II type 1 (AT1) receptor (AGTR1) antagonist. ...